Skip to main content
. 2017 Aug 24;242(18):1795–1801. doi: 10.1177/1535370217728499

Figure 1.

Figure 1

Western Blot results of three EMT members from 20 controls, 20 BPH, and 40 metastatic samples. Periostin and Fibronectin showing quite high expression levels in metastatic group compared to control and BPH groups. In the majority of metastatic samples, integrin-α4 showed very low or no expression in comparison to the control and BPH groups (C: control; BPH: benign prostatic hyperplasia; MET: metastatic)